Abstract
Abnormal circadian rhythm is quite common in PD patients, such as sleep-wake cycles, motor symptoms fluctuation, endocrine changes, autonomic dysfunction, and so on. It may have a negative effect on life quality of the patients. In addition, the disrupted biorhythm may alter the anti-oxidative ability, the autophagy level, and the mitochondrial function and thus accelerate disease progression. Recent studies showed that biorhythm modification, such as light therapy and physical exercise, can improve the motor symptoms and delay disease progression. Based on this, neurological clinicians should get more attention to circadian dysfunction of PD, and the circadian therapy may be a new hopeful strategy for PD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Edgar RS, et al. Peroxiredoxins are conserved markers of circadian rhythms. Nature. 2012;485:459–64. https://doi.org/10.1038/nature11088.
Konopka RJ, Benzer S. Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci U S A. 1971;68:2112–6.
Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet. 2004;5:407–41. https://doi.org/10.1146/annurev.genom.5.061903.175925.
Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4:649–61. https://doi.org/10.1038/nrn1177.
O’Neill JS, Reddy AB. Circadian clocks in human red blood cells. Nature. 2011;469:498–503. https://doi.org/10.1038/nature09702.
Buhr ED, Takahashi JS. Molecular components of the mammalian circadian clock. Handb Exp Pharmacol. 2013;217:3–27. https://doi.org/10.1007/978-3-642-25950-0_1.
Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–49. https://doi.org/10.1146/annurev-physiol-021909-135821.
Liu AC, et al. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell. 2007;129:605–16. https://doi.org/10.1016/j.cell.2007.02.047.
Mohawk JA, Takahashi JS. Cell autonomy and synchrony of suprachiasmatic nucleus circadian oscillators. Trends Neurosci. 2011;34:349–58. https://doi.org/10.1016/j.tins.2011.05.003.
Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal resetting cue for mammalian circadian oscillators. Science. 2010;330:379–85. https://doi.org/10.1126/science.1195262.
Yang X, Lamia KA, Evans RM. Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harb Symp Quant Biol. 2007;72:387–94. https://doi.org/10.1101/sqb.2007.72.058.
Huang N, et al. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science. 2012;337:189–94. https://doi.org/10.1126/science.1222804.
Kume K, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999;98:193–205.
Busino L, et al. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science. 2007;316:900–4. https://doi.org/10.1126/science.1141194.
Siepka SM, et al. Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell. 2007;129:1011–23. https://doi.org/10.1016/j.cell.2007.04.030.
Sato TK, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 2004;43:527–37. https://doi.org/10.1016/j.neuron.2004.07.018.
Preitner N, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 2002;110:251–60.
Ukai-Tadenuma M, et al. Delay in feedback repression by cryptochrome 1 is required for circadian clock function. Cell. 2011;144:268–81. https://doi.org/10.1016/j.cell.2010.12.019.
Liu AC, et al. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 2008;4:e1000023. https://doi.org/10.1371/journal.pgen.1000023.
Crosio C, Cermakian N, Allis CD, Sassone-Corsi P. Light induces chromatin modification in cells of the mammalian circadian clock. Nat Neurosci. 2000;3:1241–7. https://doi.org/10.1038/81767.
Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006;125:497–508. https://doi.org/10.1016/j.cell.2006.03.033.
Duong HA, Robles MS, Knutti D, Weitz CJ. A molecular mechanism for circadian clock negative feedback. Science. 2011;332:1436–9. https://doi.org/10.1126/science.1196766.
Naruse Y, et al. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. Mol Cell Biol. 2004;24:6278–87. https://doi.org/10.1128/MCB.24.14.6278-6287.2004.
Feng D, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science. 2011;331:1315–9. https://doi.org/10.1126/science.1198125.
Keene AC, Duboue ER. The origins and evolution of sleep. J Exp Biol. 2018;221:jeb159533. https://doi.org/10.1242/jeb.159533.
Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–9. https://doi.org/10.1016/S0140-6736(99)01376-8.
Ding F, et al. Changes in the composition of brain interstitial ions control the sleep-wake cycle. Science. 2016;352:550–5. https://doi.org/10.1126/science.aad4821.
Tononi G, Cirelli C. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron. 2014;81:12–34. https://doi.org/10.1016/j.neuron.2013.12.025.
de Vivo L, et al. Ultrastructural evidence for synaptic scaling across the wake/sleep cycle. Science. 2017;355:507–10. https://doi.org/10.1126/science.aah5982.
Marshall L, Helgadottir H, Molle M, Born J. Boosting slow oscillations during sleep potentiates memory. Nature. 2006;444:610–3. https://doi.org/10.1038/nature05278.
Blum ID, Bell B, Wu MN. Time for bed: genetic mechanisms mediating the circadian regulation of sleep. Trends Genet. 2018;34:379–88. https://doi.org/10.1016/j.tig.2018.01.001.
Toh KL, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291:1040–3.
Patke A, et al. Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell. 2017;169:203–215 e213. https://doi.org/10.1016/j.cell.2017.03.027.
Zhang L, et al. A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood trait. Proc Natl Acad Sci U S A. 2016;113:E1536–44. https://doi.org/10.1073/pnas.1600039113.
Xu Y, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434:640–4. https://doi.org/10.1038/nature03453.
Katzenberg D, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998;21:569–76.
Hirano A, et al. A Cryptochrome 2 mutation yields advanced sleep phase in humans. elife. 2016;5:e16695. https://doi.org/10.7554/eLife.16695.
He Y, et al. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325:866–70. https://doi.org/10.1126/science.1174443.
Pellegrino R, et al. A novel BHLHE41 variant is associated with short sleep and resistance to sleep deprivation in humans. Sleep. 2014;37:1327–36. https://doi.org/10.5665/sleep.3924.
Ebisawa T, et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep. 2001;2:342–6. https://doi.org/10.1093/embo-reports/kve070.
Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010;11:589–99. https://doi.org/10.1038/nrn2868.
Sterniczuk R, Dyck RH, Laferla FM, Antle MC. Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: part 1. Circadian changes. Brain Res. 2010;1348:139–48. https://doi.org/10.1016/j.brainres.2010.05.013.
Kudo T, Loh DH, Truong D, Wu Y, Colwell CS. Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol. 2011;232:66–75. https://doi.org/10.1016/j.expneurol.2011.08.003.
Oakeshott S, et al. Circadian abnormalities in motor activity in a BAC transgenic mouse model of Huntington’s disease. PLoS Curr. 2011;3:RRN1225. https://doi.org/10.1371/currents.RRN1225.
Kondratova AA, Kondratov RV. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci. 2012;13:325–35. https://doi.org/10.1038/nrn3208.
Altun A, Ugur-Altun B. Melatonin: therapeutic and clinical utilization. Int J Clin Pract. 2007;61:835–45. https://doi.org/10.1111/j.1742-1241.2006.01191.x.
Reiter RJ, Acuna-Castroviejo D, Tan DX, Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci. 2001;939:200–15.
Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. 2005;27:119–30.
Bordet R, et al. Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol. 2003;26:65–72.
Bolitho SJ, et al. Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep Med. 2014;15:342–7. https://doi.org/10.1016/j.sleep.2013.10.016.
Videnovic A, et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 2014;71:463–9. https://doi.org/10.1001/jamaneurol.2013.6239.
Breen DP, et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 2014;71:589–95. https://doi.org/10.1001/jamaneurol.2014.65.
Feng Z, et al. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer’s disease. J Pineal Res. 2004;37:129–36. https://doi.org/10.1111/j.1600-079X.2004.00144.x.
Mishima K, et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol Psychiatry. 1999;45:417–21.
Singer C, et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep. 2003;26:893–901.
Aziz NA, et al. Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease. J Neurol. 2009;256:1961–5. https://doi.org/10.1007/s00415-009-5196-1.
Kondratov RV, Vykhovanets O, Kondratova AA, Antoch MP. Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging (Albany NY). 2009;1:979–87. https://doi.org/10.18632/aging.100113.
Klionsky DJ. Autophagy revisited: a conversation with Christian de Duve. Autophagy. 2008;4:740–3.
Ma D, Panda S, Lin JD. Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J. 2011;30:4642–51. https://doi.org/10.1038/emboj.2011.322.
Reme C, Wirz-Justice A, Rhyner A, Hofmann S. Circadian rhythm in the light response of rat retinal disk-shedding and autophagy. Brain Res. 1986;369:356–60.
Pfeifer U, Scheller H. A morphometric study of cellular autophagy including diurnal variations in kidney tubules of normal rats. J Cell Biol. 1975;64:608–21.
Huang G, Zhang F, Ye Q, Wang H. The circadian clock regulates autophagy directly through the nuclear hormone receptor Nr1d1/rev-erbalpha and indirectly via Cebpb/(C/ebpbeta) in zebrafish. Autophagy. 2016;12:1292–309. https://doi.org/10.1080/15548627.2016.1183843.
He Y, et al. Circadian rhythm of autophagy proteins in hippocampus is blunted by sleep fragmentation. Chronobiol Int. 2016;33:553–60. https://doi.org/10.3109/07420528.2015.1137581.
Li S, Wang Y, Wang F, Hu LF, Liu CF. A new perspective for Parkinson’s disease: circadian rhythm. Neurosci Bull. 2017;33:62–72. https://doi.org/10.1007/s12264-016-0089-7.
Rothman SM, Mattson MP. Sleep disturbances in Alzheimer’s and Parkinson’s diseases. NeuroMolecular Med. 2012;14:194–204. https://doi.org/10.1007/s12017-012-8181-2.
Shen Y, Huang JY, Li J, Liu CF. Excessive daytime sleepiness in Parkinson’s disease: clinical implications and management. Chin Med J. 2018;131:974–81. https://doi.org/10.4103/0366-6999.229889.
van Hilten JJ, et al. Diurnal effects of motor activity and fatigue in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1993;56:874–7.
Bonuccelli U, et al. Diurnal motor variations to repeated doses of levodopa in Parkinson’s disease. Clin Neuropharmacol. 2000;23:28–33.
Piccini P, et al. Diurnal worsening in Parkinson patients treated with levodopa. Riv Neurol. 1991;61:219–24.
Fertl E, Auff E, Doppelbauer A, Waldhauser F. Circadian secretion pattern of melatonin in Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1991;3:41–7.
Breen DP, et al. Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease. Mov Disord. 2016;31:1062–6. https://doi.org/10.1002/mds.26592.
Bogaerts V, Theuns J, van Broeckhoven C. Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria? Genes Brain Behav. 2008;7:129–51. https://doi.org/10.1111/j.1601-183X.2007.00342.x.
Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging. 1997;18:285–9.
Mizobuchi M, Hineno T, Kakimoto Y, Hiratani K. Increase of plasma adrenocorticotrophin and cortisol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated dogs. Brain Res. 1993;612:319–21.
Zhong G, Bolitho S, Grunstein R, Naismith SL, Lewis SJ. The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson’s disease. PLoS One. 2013;8:e72661. https://doi.org/10.1371/journal.pone.0072661.
Cagnacci A, et al. Effect of naloxone on body temperature in postmenopausal women with Parkinson’s disease. Life Sci. 1990;46:1241–7.
Suzuki K, et al. Circadian variation of core body temperature in Parkinson disease patients with depression: a potential biological marker for depression in Parkinson disease. Neuropsychobiology. 2007;56:172–9. https://doi.org/10.1159/000119735.
Schmidt C, et al. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord. 2009;24:2136–42. https://doi.org/10.1002/mds.22767.
Ejaz AA, Sekhon IS, Munjal S. Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson’s disease. Eur J Intern Med. 2006;17:417–20. https://doi.org/10.1016/j.ejim.2006.02.020.
Berganzo K, et al. Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related? J Neurol. 2013;260:1752–6. https://doi.org/10.1007/s00415-013-6859-5.
Ruan GX, Allen GC, Yamazaki S, McMahon DG. An autonomous circadian clock in the inner mouse retina regulated by dopamine and GABA. PLoS Biol. 2008;6:e249. https://doi.org/10.1371/journal.pbio.0060249.
Struck LK, Rodnitzky RL, Dobson JK. Circadian fluctuations of contrast sensitivity in Parkinson’s disease. Neurology. 1990;40:467–70.
Cai Y, Liu S, Sothern RB, Xu S, Chan P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson’s disease. Eur J Neurol. 2010;17:550–4. https://doi.org/10.1111/j.1468-1331.2009.02848.x.
Ding H, et al. Decreased expression of Bmal2 in patients with Parkinson’s disease. Neurosci Lett. 2011;499:186–8. https://doi.org/10.1016/j.neulet.2011.05.058.
Gu Z, et al. Association of ARNTL and PER1 genes with Parkinson’s disease: a case-control study of Han Chinese. Sci Rep. 2015;5:15891. https://doi.org/10.1038/srep15891.
Hood S, et al. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci. 2010;30:14046–58. https://doi.org/10.1523/JNEUROSCI.2128-10.2010.
Mattam U, Jagota A. Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson’s disease male Wistar rat model and effect of melatonin administration. Biogerontology. 2015;16:109–23. https://doi.org/10.1007/s10522-014-9541-0.
Lin Q, et al. Promoter methylation analysis of seven clock genes in Parkinson’s disease. Neurosci Lett. 2012;507:147–50. https://doi.org/10.1016/j.neulet.2011.12.007.
Dudley CA, et al. Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice. Science. 2003;301:379–83. https://doi.org/10.1126/science.1082795.
Bunger MK, et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 2000;103:1009–17.
Xie Z, et al. Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation. J Clin Invest. 2015;125:324–36. https://doi.org/10.1172/JCI76881.
Kandalepas PC, Mitchell JW, Gillette MU. Melatonin signal transduction pathways require E-box-mediated transcription of Per1 and Per2 to reset the SCN clock at dusk. PLoS One. 2016;11:e0157824. https://doi.org/10.1371/journal.pone.0157824.
Paus S, et al. Bright light therapy in Parkinson’s disease: a pilot study. Mov Disord. 2007;22:1495–8. https://doi.org/10.1002/mds.21542.
Willis GL, Turner EJ. Primary and secondary features of Parkinson’s disease improve with strategic exposure to bright light: a case series study. Chronobiol Int. 2007;24:521–37. https://doi.org/10.1080/07420520701420717.
Willis GL, Moore C, Armstrong SM. A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson’s disease. Rev Neurosci. 2012;23:199–226. https://doi.org/10.1515/revneuro-2011-0072.
Yamanaka Y, et al. Differential regulation of circadian melatonin rhythm and sleep-wake cycle by bright lights and nonphotic time cues in humans. Am J Physiol Regul Integr Comp Physiol. 2014;307:R546–57. https://doi.org/10.1152/ajpregu.00087.2014.
Yamanaka Y, et al. Morning and evening physical exercise differentially regulate the autonomic nervous system during nocturnal sleep in humans. Am J Physiol Regul Integr Comp Physiol. 2015;309:R1112–21. https://doi.org/10.1152/ajpregu.00127.2015.
Yasumoto Y, Nakao R, Oishi K. Free access to a running-wheel advances the phase of behavioral and physiological circadian rhythms and peripheral molecular clocks in mice. PLoS One. 2015;10:e0116476. https://doi.org/10.1371/journal.pone.0116476.
Fonken LK, et al. Microglia inflammatory responses are controlled by an intrinsic circadian clock. Brain Behav Immun. 2015;45:171–9. https://doi.org/10.1016/j.bbi.2014.11.009.
Neufeld-Cohen A, et al. Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins. Proc Natl Acad Sci U S A. 2016;113:E1673–82. https://doi.org/10.1073/pnas.1519650113.
Li SY, et al. Long-term levodopa treatment accelerates the circadian rhythm dysfunction in a 6-hydroxydopamine rat model of Parkinson’s disease. Chin Med J. 2017;130:1085–92. https://doi.org/10.4103/0366-6999.204920.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Huang, GD., Wang, YL. (2020). Circadian Rhythms Disruption. In: Liu, CF. (eds) Sleep Disorders in Parkinson’s Disease. Springer, Singapore. https://doi.org/10.1007/978-981-15-2481-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-15-2481-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2480-6
Online ISBN: 978-981-15-2481-3
eBook Packages: MedicineMedicine (R0)